Matthew Derrick to Respiratory Distress Syndrome, Newborn
This is a "connection" page, showing publications Matthew Derrick has written about Respiratory Distress Syndrome, Newborn.
Connection Strength
0.591
-
A Survey of Minimally Invasive Surfactant Use in the United States. Am J Perinatol. 2025 Jun; 42(8):1043-1050.
Score: 0.216
-
Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial. JAMA. 2023 09 19; 330(11):1054-1063.
Score: 0.199
-
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial. JAMA. 2021 12 28; 326(24):2478-2487.
Score: 0.176